Gene expression profiling in spleens of deoxynivalenol-exposed mice: Immediate early genes as primary targets

Journal of Toxicology and Environmental Health - Part A

Volumn 67, Issue 18, 2004, Pages 1423-1441

  Kinser, Shawn ^a   Jia, Qunshan ^a   Li, Maioxing ^a   Laughter, Ashley ^b   Cornwell, Paul D ^b,c   Corton, J Christopher ^b,d   Pestka, James J ^a,e  

^a Michigan State University   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c ROSETTA INPHARMATICS   (United States)

^d Toxic Genomics   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; EPOXIDE HYDROLASE; HEAT SHOCK PROTEIN 40; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; NUCLEOTIDE BINDING PROTEIN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN TYROSINE PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; VOMITOXIN;

ANIMAL TISSUE; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENE TARGETING; IMMUNITY; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; CHEMOKINES; CHEMOTAXIS; CYTOKINES; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENES, IMMEDIATE-EARLY; HYDROLASES; INFLAMMATION; LINEAR MODELS; MICE; MICE, INBRED STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYLOGENY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; TOXICOGENETICS; TRANSCRIPTION FACTORS; TRICHOTHECENES; UP-REGULATION;

ANIMALIA; MURINAE;

EID: 4444248155     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/15287390490483827     Document Type: Article

References (95)

1. Abouzied, M. M., Azcona, J. I., Braselton, W. E., and Pestka, J. J. 1991. Immunochemical assessment of mycotoxins in 1989 grain foods: Evidence for deoxynivalenol (vomitoxin) contamination. Appl. Environ. Microbiol. 57:672-677.
2. Alessi, D. R., Smythe, C., and Keyse, S. M. 1993. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 8:2015-2020.
3. Azcona-Olivera, J. I., Ouyang, Y., Murtha, J., Chu, F. S., and Pestka, J. J. 1995. Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): Relationship to toxin distribution and protein synthesis inhibition. Toxicol. Appl. Pharmacol. 133:109-120.
4. Babic, A. M., Kireeva, M. L., Kolesnikova, T. V., and Lau, L. F. 1998. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95:6355-6360.
5. Barton, B. E. 1997. IL-6: Insights into novel biological activities. Clin. Immunol. Immunopathol. 85:16-20.
6. Bhalla, U. S., Ram, P. T., and Iyengar, R. 2002. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297:1018-1023.
7. Blake, J. A., Richardson, J. E., Bull, C. J., Kadin, J. A., Eppig, J. T., and the members of the Mouse Genome Database Group. 2003. MGD: The mouse genome database. Nucleic Acids Res. 31:193-195.
8. Bozza, M., Bliss, J. L., Dorner, A. J., and Trepicchio, W. L. 2001. Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J. Interferon Cytokine Res. 21:21-30.
9. Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y. S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., Hewett, T. E., and Molkentin, J. D. 2003. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J. Clin. Invest. 111:1475-1486.
10. Brondello, J. M., Pouyssegur, J., and McKenzie, F. R. 1999. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286:2514-2517.
11. Brzoska, P. M., Chen, H., Levin, N. A., Kuo, W. L., Collins, C., Fu, K. K., Gray, J. W., and Christman, M. F. 1996. Cloning, mapping, and in vivo localization of a human member of the PKCI-1 protein family (PRKCNH1). Genomics 36:151-156.
12. Bueno, O. F., Brandt, E. B., Rothenberg, M. E., and Molkentin, J. D. 2002. Defective T cell development and function in calcineurin A β-deficient mice. Proc. Natl. Acad. Sci. USA 99:9398-9403.
13. Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., and Molkentin, J. D. 2002b. Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice. Proc. Natl. Acad. Sci. USA 99:4586-4591.
14. Canady, R. A., Coker, R. D., Egan, S. K., Krska, R., Kuiper-Goodman, T., Olsen, M., Pestka, J., Resnik, S., and Schlatter, J. 2001. Deoxynivalenol. In Safety evaluation of certain mycotoxins in food, pp. 420-529. Geneva: World Health Organization.
15. Cerutti, A., Zan, H., Schaffer, A., Bergsagel, L., Harindranath, N., Max, E. E., and Casali, P. 1998. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J. Immunol. 160:2145-2157.
16. Chellaiah, A., Davis, A., and Mohanakumar, T. 1993. Cloning of a unique human homologue of the Escherichia coli DNAJ heat shock protein. Biochim. Biophys. Acta 1174:111-113.
17. Chung, Y. J., Zhou, H. R., and Pestka, J. J. 2003a. Transcriptional and post-transcriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-α expression by deoxynivalenol (vomitoxin). Toxicol. Appl. Pharmacol. 193:188-201.
18. Chung, Y. J., Yang, G. H., Islam, Z., and Pestka, J. J. 2003b. Up-regulation of macrophage inflammatory protein-2 and complement 3A receptor by the trichothecenes deoxynivalenol and satratoxin G. Toxicology 186:51-65.
19. Cloutier, J. F., and Veillette, A. 1996. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J. 15:4909-4918.
20. Crawford, P. A., Sadovsky, Y., Woodson, K., Lee, S. L., and Milbrandt, J. 1995. Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol. Cell. Biol. 15:4331-4416.
21. de la Fuente-Garcia, M. A., Nicolas, J. M., Freed, J. H., Palou, E., Thomas, A. P., Vilella, R., Vives, J., and Gaya, A. 1998. CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91:2800-2809.
22. Delhanty, P. J. 1998. Interleukin-1 beta suppresses growth hormone-induced acid-labile subunit mRNA levels and secretion in primary hepatocytes. Biochem. Biophys. Res. Commun. 243:269-272.
23. Deng, G. Y., Muir, A., Maclaren, N. K., and She, J. X. 1995. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am. J. Hum. Genet. 56:528-534.
24. Dodds, R. A., Merry, K., Littlewood, A., and Gowen, M. 1994. Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage. J. Histochem. Cytochem. 42:733-744.
25. Du, X., and Williams, D. A. 1997. Interleukin-11: Review of molecular, cell biology, and clinical use. Blood 89:3897-3908.
26. Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., and Luster, A. D. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:3195-3204.
27. Eppig, J. T., Blake, J. A., Burkhard, D. L., Goldsmith, C. W., Lutz, C. M., and Smith, C. L. 2002. Corralling conditional mutations: A unified resource for mouse phenotypes. Genesis 32:63-65.
28. Fan, J., Wojnar, M. M., Theodorakis, M., and Lang, C. H. 1996. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am. J. Physiol. 270:R621-R629.
29. Fehling, H. J., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U., and von Boehmer, H. 1994. MHC class I expression in mice lacking the proteosome subunit LMP-7. Science 265:1234-1237.
30. Fernandez, P. M., Brunel, F., Jimenez, M. A., Saez, J. M., Cereghini, S., and Zakin, M. M. 2000. Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis. Endocrinology 141:2392-2400.
31. Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., and Ronai, Z. 1998. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 12:2658-2663.
32. Gene Ontology Consortium. 2001. Creating the gene ontology resource: Design and implementation. Genome Res. 11:1425-1433.
33. Glynne, R., Powis, S. H., Beck, S., Kelly, A., Kerr, L. A., and Trowsdale, J. 1991. A proteosome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:357-360.
34. Goehler, L. E., Relton, J. K., Dripps, D., Kiechle, R., Tartaglia, N., Maier, S. F., and Watkins, L. R. 1997. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: A possible mechanism for immune-to-brain communication. Brain Res. Bull. 43:357-364.
35. Hansen, M. K., Taishi, P., Chen, Z., and Krueger, J. M. 1998. Vagotomy blocks the induction of interleukin-1β (IL-1β) mRNA in the brain of rats in response to systemic IL-1β. J. Neurosci. 18:2247-2253.
36. Harries, H. M., Fletcher, S. T., Duggan, C. M., and Baker, V. A. 2001. The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol. In Vitro 15:399-405.
37. Henry, C. J., Phillips, R., Carpanini, F., Corton, J. C., Craig, K., Igarashi, K., Leboeuf, R., Marchant G., Osborn, K., Pennie, W. D., Smith, L. L., Teta, M. J., and Vu, V. 2002. Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop. Environ. Health Perspect. 110:1047-1050.
38. Islam, Z., and Pestka, J. J. 2003. Role of IL-1(β) in endotoxin potentiation of deoxynivalenol-induced corticosterone response and leukocyte apoptosis in mice. Toxicol. Sci. 74:93-102.
39. Jackson, L. S., and Bullerman, L. B. 1999. Effect of processing on Fusarium mycotoxins. Adv. Exp. Med. Biol. 459:243-261.
40. Ji, G. E., Park, S. Y., Wong, S. S., and Pestka, J. J. 1998. Modulation of nitric oxide, hydrogen peroxide and cytokine production in a clonal macrophage model by the trichothecene vomitoxin (deoxynivalenol). Toxicology 125:203-214.
41. Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Derijard, B., Moore, G., Davis, R., and Karin, M. 1994. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8:2996-3007.
42. Kepler, T. B., Crosby, L., and Morgan, K. T. 2002. Normalization and analysis of DNA microarray data by self-consistency and local regression. Genome Biol. 3:37.1-37.11.
43. Kohler, N. G., and Joly, A. 1997. The involvement of an LPS inducible I kappa B kinase in endotoxin tolerance. Biochem. Biophys. Res. Commun. 232:602-607.
44. Kravchenko, L. V., Tutelyan, V. A., Vasilyev, A. V., Kranauskas, A. E., and Avrenyeva, L. I. 1986. Biochemical changes in subacute mycotoxicosis induced by T-2 toxin in rats. Toxicology 42:77-83.
45. Kunkel, E. J., and Butcher, E. C. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3:822-829.
46. Kusano, K., Miyaura, C., Inada, M., Tamura, T., Ito, A., Nagase, H., Kamoi, K., and Suda, T. 1998. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption. Endocrinology 139:1338-1345.
47. 2 in human umbilical vein endothelial cells. J. Biol. Chem. 277:46248-46255.
48. Li, Q., Park, P. W., Wilson, C. L., and Parks, W. C. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635-646.
49. Li, S., Ouyang, Y., Yang, G. H., and Pestka, J. J. 2000. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol). Toxicol. Appl. Pharmacol. 163:17-25.
50. Li, S., Ouyang, Y. L., Dong, W., and Pestka, J. J. 1997. Superinduction of IL-2 gene expression by vomitoxin (deoxynivalenol) involves increased mRNA stability. Toxicol. Appl. Pharmacol. 147:331-342.
51. Ling, Z., Chen, M. C., Smismans, A., Pavlovic, D., Schuit, F., Eizirik, D. L., and Pipeleers, D. G. 1998a. Intercellular differences in interleukin 1beta-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic ?-cells. Endocrinology 139:1540-1545.
52. Ling, Z. D., Potter, E. D., Lipton, J. W., and Carvey, P. M. 1998b. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neurol. 149:411-423.
53. Mandrup-Poulsen, T. 1996. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029.
54. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13:265-270.
55. Matthews, R. J., Bowne, D. B., Flores, E., and Thomas, M. L. 1992. Characterization of hematopoietic intracellular protein tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol. Cell Biol. 12:2396-2405.
56. Miller, K., and Atkinson, H. A. 1986. The in vitro effects of trichothecenes on the immune system. Food Chem. Toxicol. 24:545-549.
57. Moon, Y., and Pestka, J. J. 2002. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol. Sci. 69:373-382.
58. Moon, Y., and Pestka, J. J. 2003. Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin (deoxynivalenol) in vitro and in vivo. Toxicol. Appl. Pharmacol. 187:80-88.
59. Omiecinski, C. J., Hassett, C., and Hosagrahara, V. 2000. Epoxide hydrolase-Polymorphism and role in toxicology. Toxicol. Lett. 112-113:365-370.
60. Ouyang, Y. L., Azcona-Olivera, J. I., Murtha, J., and Pestka, J. J. 1996a. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T Cells stimulated with phorbol ester and calcium ionophore: Relation to kinetics of proliferation. Toxicol. Appl. Pharmacol. 138:324-334.
61. Ouyang, Y. L., Azcona-Olivera, J. I., Murtha, J., and Pestka, J. J. 1996b. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: Relation to kinetics of proliferation. Toxicol. Appl. Pharmacol. 138:324-334.
62. Ouyang, Y. L., Li, S., and Pestka, J. J. 1996c. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-κ B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells. Toxicol. Appl. Pharmacol. 140:328-336.
63. Paul, S. R., Bennett, F., Calvetti, J. A., Kelleher, K., Wood, C. R., O'Hara, R. M., Jr., Leary, A. C., Sibley, B., Clark, S. C., and Williams, D. A. 1990. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87:7512-7516.
64. Pestka, J. J. 2003. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol. Lett. 11:140-141:287-295.
65. Pestka, J. J., and Zhou, H. R. 2000. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion. Food Chem. Toxicol. 38:565-575.
66. Plata-Salaman, C. R. 1994. Meal patterns in response to the intracerebroventricular administration of interleukin-1 beta in rats. Physiol. Behav. 55:727-733.
67. Plata-Salaman, C. R., and Ilyin, S. E. 1997. Interleukin-1β (IL-1β)-induced modulation of the hypothalamic IL-1β system, tumor necrosis factor-alpha, and transforming growth factor-beta1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: Implications to IL-1β feedback systems and cytokine-cytokine interactions. J. Neurosci. Res. 49:541-550.
68. Robbana-Barnat, S., Loridon-Rosa, B., Cohen, H., Lafarge-Frayssinet, C., Neish, G.A., and Frayssinet, C. 1987. Protein synthesis inhibition and cardiac lesions associated with deoxynivalenol ingestion in mice. Food Addit. Contam. 4:49-56.
69. Rotter, B. A., Prelusky, D. B., and Pestka, J. J. 1996. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 48:1-34.
70. Shadiack, A. M., Hart, R. P., Carlson, C. D., and Jonakait, G. M. 1993. Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J. Neurosci. 13:2601-2609.
71. Sherman, Y., More, R., Yagen, B., and Yarom, R. 1987. Cardiovascular pathology induced by passive transfer of splenic cells from syngeneic rats treated with T-2 toxin. Toxicol. Lett. 36:15-22.
72. Stocco, C. O., Lau, L. F., and Gibori, G. 2002. A calcium/calmodulin- dependent activation of ERK 1/2 mediates JunD phosphorylation and induction of nur77 and 20α-hsd genes by prostaglandin F2alpha in ovarian cells. J. Biol. Chem. 277:3293-3302.
73. Su, T., Suzui, M., Wang, L., Lin, C. S., Xing, W. Q., and Weinstein, I. B. 2003. Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc. Natl. Acad. Sci. USA 100:7824-7829.
74. Takeuchi, Y., Watanabe, S., Ishii, G., Takeda, S., Nakayama, K., Fukumoto, S., Kaneta, Y., Inoue, D., Matsumoto, T., Harigaya, K., and Fujita, T. 2002. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J. Biol. Chem. 277:49011-49018.
75. Tanaka, T., Hasegawa, A., Yamamoto, S., Lee, U. S., Sugiura, Y., and Ueno, Y. 1988. Worldwide contamination of cereals by the Fusarium mycotoxins nivalenol, deoxynivalenol, and zearalenone. 1. Survey of 19 Countries. J. Agric. Food Chem. 36:981-983.
76. Tulchinsky, E. 2000. Fos family members: Regulation, structure and role in oncogenic transformation. Histol. Histopathol. 15:921-928.
77. Ueno, Y. 1987. Trichothecenes in food. In Mycotoxins in food, ed. P. Krogh, pp. 123-147, Academic Press, London.
78. Van Snick, J. 1990. Interleukin-6: An overview. Annu. Rev. Immunol. 8:253-278.
79. Virca, G. D., Kim, S. Y., Glaser, K. B., and Ulevitch, R. J. 1989. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J. Biol. Chem. 264:21951-21956.
80. Wansa, K. D., Harris, J. M., and Muscat, G. E. 2002. The activation function-1 domain of Nur77/ NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J. Biol. Chem. 277:33001-33011.
81. Warner, R. L., Brooks, K., and Pestka, J. J. 1994. In vitro effects of vomitoxin (deoxynivalenol) on lymphocyte function: Enhanced interleukin production and help for IgA secretion. Food Chem. Toxicol. 32:617-625.
82. Witt, M. F., Hart, L. P., and Pestka, J. J. 1985. Purification of deoxynivalenol (vomitoxin) by water-saturated silica gel chromatography. J. Agric. Food Chem. 33:745-748.
83. Wittwer, C. T., Herrmann, M. G., Gundry, C. N., and Elenitoba-Johnson, K. S. 2001. Real-time multiplex PCR assays. Methods 25:430-442.
84. Wolpe, S. D., Sherry, B., Juers, D., Davatelis, G., Yurt, R. W., and Cerami, A. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86:612-616.
85. Wong, S., Schwartz, R. C., and Pestka, J. J. 2001. Superinduction of TNF-α and IL-6 in macrophages by vomitoxin (deoxynivalenol) modulated by mRNA stabilization. Toxicology 161:139-149.
86. Wong, S. S., Zhou, H. R., Marin-Martinez, M. L., Brooks, K., and Pestka, J. J. 1998. Modulation of IL-1β, IL-6 and TNF-α secretion and mRNA expression by the trichothecene vomitoxin in the RAW 264.7 murine macrophage cell line. Food Chem. Toxicol. 36:409-419.
87. Wong, S. S., Zhou, H. R., and Pestka, J. J. 2002. Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-κB, and NF-IL6 in raw 264.7 macrophage cells. J. Toxicol. Environ. Health A 65:1161-1180.
88. Yan, D., Zhou, H. R., Brooks, K. H., and Pestka, J. J. 1998. Role of macrophages in elevated IgA and IL-6 production by Peyer's patch cultures following acute oral vomitoxin exposure. Toxicol. Appl. Pharmacol. 148:261-273.
89. Yang, G. H., Li, S., and Pestka, J. J. 2000. Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (deoxynivalenol). Toxicol. Appl. Pharmacol. 162:207-217.
90. Yazdanpanah, H., Roshanzamir, F., Shafaghi, B., Faizi, M., Elhami, M., and Rasekh, H. R. 1997. Assessment of possible protective roles of selenium, zinc, and cis-stilbene oxide against acute T-2 toxin poisoning: A preliminary report. Nat. Toxins 5:133-135.
91. Zheng, H., Fletcher, D., Kozak, W., Jiang, M., Hofmann, K. J., Conn, C. A., Soszynski, D., Grabiec, C., Trumbauer, M. E., and Shaw, A. 1995. Resistance to fever induction and impaired acute-phase response in interleukin-1β- deficient mice. Immunity 3:9-19.
92. Zhou, H. R., Islam, Z., and Pestka, J. J. 2003. Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin. Toxicol. Sci. 72:130-142.
93. Zhou, H. R., Yan, D., and Pestka, J. J. 1997. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): Dose response and time course. Toxicol. Appl. Pharmacol. 144:294-305.
94. Zhou, H. R., Yan, D., and Pestka, J. J. 1998. Induction of cytokine gene expression in mice after repeated and subchronic oral exposure to vomitoxin (deoxynivalenol): Differential toxin-induced hyporesponsiveness and recovery. Toxicol. Appl. Pharmacol. 151:347-358.
95. Ziegler-Heitbrock, H. W., Blumenstein, M., Kafferlein, E., Kieper, D., Petersmann, I., Endres, S., Flegel, W. A., Northoff, H., Riethmuller, G., and Haas, J. G. 1992. In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 75:264-268.